Ceftriaxone

Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes purimox® powder grade e (amoxillin trihydrate). Characteristics: a fine crystalline powder produced using green enzymatic technology in a sustainable and environmentally friendly manner. No solvents are use...

Rosuvastatin

Ampicillin Sulbactam Injectables

Cefazolin Injectables

Cefepime Injectables

Cefotaxime Injectables

Piperacillin Tazobactam Injectable

Piperacillin Tazobactam Injectables

Piperacillin Tazobactam Injectables

Piperacillin Tazobactam Injectables

Penicillin G Penicillin G potassium Penicillin G procaine Penicillin G procaine sterile* Penicillin G benzathine sterile*
Beta-lactam Intermediates 6-amino-penicillanic acid (6-APA) 7-amino-deacetoxycephalosporanic acid (7-ADCA)
Semi-Synthetic Penicillins Amoxicillin trihydrate Ampicillin trihydr...

Finished Dosage Forms
Beta-lactam antibiotics
Amoxicillin Amoxicillin + Clavulanic acid
Statins
Atorvastatin Rosuvastatin
Anti-fungals
Caspofungin

Sterile injectables
Semi-Synthetic Penicillins (SSP)
Amoxicillin & Cloxacillin Ampicillin Sodium Amoxicill...

Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

Available Marketing Authorizations